相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm
William C. McDonald et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)
UPLC-MS/MS-based Lipidomic Profiles Revealed Aberrant Lipids Associated with Invasiveness of Silent Corticotroph Adenoma
Zihao Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
The silent variants of pituitary tumors: demographic, radiological and molecular characteristics
M. E. Torregrosa-Quesada et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases
Keyi Zhang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
The Pangenomic Classification of Pituitary Neuroendocrine Tumors: Quality Histopathology is Required for Accurate Translational Research
Ozgur Mete et al.
ENDOCRINE PATHOLOGY (2021)
Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system
Shenzhong Jiang et al.
PITUITARY (2021)
Recent Understanding and Future Directions of Recurrent Corticotroph Tumors
Jose Miguel Hinojosa-Amaya et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors
Abhijit Goyal-Honavar et al.
ACTA NEUROCHIRURGICA (2021)
Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease
Takako Araki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach
Masaaki Yamamoto et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Long-Term Use of Temozolomide as Safe and Effective Therapy for an Aggressive Corticotroph Adenoma in a Very Old Patient
Maria Chiara Decaroli et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics
Xinjie Bao et al.
THERANOSTICS (2021)
Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease
Takako Araki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Pangenomic Classification of Pituitary Neuroendocrine Tumors
Mario Neou et al.
CANCER CELL (2020)
Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas
Leandro Kasuki et al.
CLINICAL ENDOCRINOLOGY (2020)
A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas
Derya Metin-Armagan et al.
ENDOCRINE PATHOLOGY (2020)
Pituitary-Tumor Endocrinopathies
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Genetics of Pituitary Adenomas
Christina Tatsi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomas
Franz L. Ricklefs et al.
ACTA NEUROPATHOLOGICA (2020)
Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors
John Turchini et al.
ENDOCRINE PATHOLOGY (2020)
MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes
Shinsuke Uraki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature
Laura Lizzul et al.
PITUITARY (2020)
Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors
Araceli Garcia-Martinez et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Clinical, Laboratory, and Treatment Profiles of Silent Corticotroph Adenomas That Have Transformed to the Functional Type: A Case Series With a Literature Review
Guangyao Zheng et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Clinical and Pathological Aspects of Silent Pituitary Adenomas
Juliana Drummond et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Pediatric silent corticotroph pituitary adenoma and role for proton therapy: case report
Nicole Prendergast et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2019)
Long-Term Survival After Transformation of an Adrenocorticotropic Hormone-Secreting Pituitary Macroadenoma to a Silent Corticotroph Pituitary Carcinoma
Lauren E. Rotman et al.
WORLD NEUROSURGERY (2019)
Why don't corticotroph tumors always produce Cushing's disease?
A. Garcia-Martinez et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients
A. L. Pappy et al.
PITUITARY (2019)
The Role of Aberrant DNA Methylation in Misregulation of Gene Expression in Gonadotroph Nonfunctioning Pituitary Tumors
Paulina Kober et al.
CANCERS (2019)
Recurrence of Silent Corticotroph Adenomas After Primary Treatment: A Systematic Review and Meta-Analysis
Athanasios Fountas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors
Araceli Garcia-Martinez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors
Ozgur Mete et al.
MODERN PATHOLOGY (2019)
Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles
Sen Cheng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Metabolomics - A Promising Approach to Pituitary Adenomas
Oana Pinzariu et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
The Role of Single-Nucleotide Polymorphisms in Pituitary Adenomas Tumorigenesis
Sumedh S. Shah et al.
CANCERS (2019)
How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria?
Maria Eugenia Torregrosa-Quesada et al.
CANCERS (2019)
Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
Junhyung Kim et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2019)
Histopathological classification of non-functioning pituitary neuroendocrine tumors
Emilija Manojlovic-Gacic et al.
PITUITARY (2018)
Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review
Fabienne Langlois et al.
PITUITARY (2018)
New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors
Hiroshi Nishioka et al.
BRAIN TUMOR PATHOLOGY (2018)
The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes
Matthew P. Salomon et al.
CLINICAL CANCER RESEARCH (2018)
Epidemiology and biomarker profile of pituitary adenohypophysial tumors
Ozgur Mete et al.
MODERN PATHOLOGY (2018)
Dual-function injectable angiogenic biomaterial for the repair of brain tissue following stroke
Lina R. Nih et al.
NATURE MATERIALS (2018)
Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)
Nele Lenders et al.
PITUITARY (2018)
Silent corticotroph adenomas
Anat Ben-Shlomo et al.
PITUITARY (2018)
Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas
Daham Kim et al.
WORLD NEUROSURGERY (2018)
Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study
Or Cohen-Inbar et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Function of cell-cycle regulators in predicting silent pituitary adenoma progression following surgical resection
Sung Hyun Park et al.
ONCOLOGY LETTERS (2017)
Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas
Laura Sanchez-Tejada et al.
PLOS ONE (2017)
Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience
Fabienne Langlois et al.
ENDOCRINE (2017)
A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours
Evelina Sjostedt et al.
ACTA NEUROPATHOLOGICA (2017)
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
M. Beatriz S. Lopes
ACTA NEUROPATHOLOGICA (2017)
The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3
Alberto Righi et al.
ENDOCRINE (2017)
Prevalence of clinically silent corticotroph macroadenomas
Katie B. Guttenberg et al.
CLINICAL ENDOCRINOLOGY (2016)
The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite
Hasan A. Zaidi et al.
NEUROSURGICAL FOCUS (2016)
The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
Hiroshi Nishioka et al.
ENDOCRINE PATHOLOGY (2015)
Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas
Laure Cazabat et al.
CLINICAL ENDOCRINOLOGY (2014)
Silent Corticotroph Adenomas After Stereotactic Radiosurgery: A Case-Control Study
Zhiyuan Xu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas et al.
ACTA NEUROPATHOLOGICA (2013)
MicroRNA 375 Mediates the Signaling Pathway of Corticotropin-releasing Factor (CRF) Regulating Pro-opiomelanocortin (POMC) Expression by Targeting Mitogen-activated Protein Kinase 8
Nan Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Comprehensive Long-term Retrospective Analysis of Silent Corticotrophic Adenomas vs Hormone-Negative Adenomas
Arman Jahangiri et al.
NEUROSURGERY (2013)
Clinical features of silent corticotroph adenomas
Hussein Alahmadi et al.
ACTA NEUROCHIRURGICA (2012)
A classification tree approach for pituitary adenomas
Alberto Righi et al.
HUMAN PATHOLOGY (2012)
O-6-Methylguanine-DNA Methyltransferase (MGMT) Immunohistochemical Expression in Pituitary Corticotroph Adenomas
Fateme Salehi et al.
NEUROSURGERY (2012)
Silent Corticotroph Adenomas: Emory University Cohort and Comparison With ACTH-Negative Nonfunctioning Pituitary Adenomas
Adriana G. Ioachimescu et al.
NEUROSURGERY (2012)
Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors
Yuji Tani et al.
ENDOCRINE JOURNAL (2011)
Pathogenesis of pituitary tumors
Shlomo Melmed
NATURE REVIEWS ENDOCRINOLOGY (2011)
Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas
Hwa Young Cho et al.
CLINICAL ENDOCRINOLOGY (2010)
Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes
Odelia Cooper et al.
Hormones & Cancer (2010)
Differential gene expression in ACTH-secreting and non-functioning pituitary tumors
Torn Tateno et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma
Toru Tateno et al.
ENDOCRINE JOURNAL (2007)
A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas
Shozo Yamada et al.
NEUROSURGERY (2007)
Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease
Kazumi Iino et al.
PITUITARY (2007)
Secretion of high-molecular-weight adrenocorticotropic hormone from a pituitary adenoma in a patient without Cushing stigmata - Case report
A Matsuno et al.
JOURNAL OF NEUROSURGERY (2004)
Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently
KJ Bradley et al.
CLINICAL ENDOCRINOLOGY (2003)
Expression of GATA-2 in human pituitary adenomas
K Umeoka et al.
MODERN PATHOLOGY (2002)
分享论文
